The German government is facing awkward questions about why the country that developed the first approved Covid-19 vaccine has so few supplies of the jab, with vaccination rates in Germany lagging far behind the US, UK and Israel.
德國政府正面臨一個尷尬的問題：作爲研發出首款獲得批准的新冠疫苗的國家，爲什麼德國的新冠疫苗供應量如此之少？德國的新冠疫苗接種率遠遠落後於美國、英國和以色列。
您已閱讀6%（308字），剩餘94%（4627字）包含更多重要資訊，訂閱以繼續探索完整內容，並享受更多專屬服務。